Mulmit

QIAGEN N.V.QIAGEN N.V.

QGEN NYSE

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-312,089,999,000465,851,000424,880,0001.94
2024-12-311,978,214,00097,711,00083,591,0000.37
2023-12-311,965,311,000409,938,000341,303,0001.48
2022-12-312,141,518,000531,460,000423,211,0001.84
2021-12-312,251,657,000630,084,000512,599,0002.21

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2017-10-26QIAGEN NV753,012
2007-06-15QIAGEN NV10,000
2007-06-12QIAGEN NV10,000
2007-06-04QIAGEN NV50,000
2007-05-31QIAGEN NV5,000
2007-05-30QIAGEN NV30,000
2007-05-29QIAGEN NV10,000
2007-05-23QIAGEN NV17,500
2007-05-09QIAGEN NV240,000
2007-05-09QIAGEN NV240,000
2007-05-08QIAGEN NV240,000
2007-04-30QIAGEN NV340,000
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.